Healthcare & Welfare

How the nation heals the sick, cares for the vulnerable, and promotes personal responsibility-pairing compassion with agency, subsidiarity, and bodily integrity consistent with Foundational Values.

Key Takeaways

Replace universal third-party coverage with mandatory or tax-advantaged HSAs, true catastrophic insurance, and a narrow safety net for the genuinely indigent while phasing Medicare for working-age adults.
Attack long waits and rationing by liberalising scope of practice, speeding drug and device access via mutual recognition, and stripping certificate of need barriers so private capacity can expand.
Break centralised federal control over health delivery through block-grant funding, slashed admin overhead, mandated price transparency, and competitive provider models that reward outcomes over compliance.
Reduce regulatory capture and defensive medicine through faster approvals, strong medical choice and right-to-try protections, and actuarially fair incentives tied to prevention and wellness.

Current Australia

New Australia

🏥 Medicare & Universal Public Insurance

Medicare and the PBS anchor universal coverage with heavy public and regulated-private involvement, while per capita spend and NDIS costs have outpaced expectations-see AIHW health expenditure reporting for national aggregates. - as at 2026-04, confirm latest fiscal tables in Budget papers.

Medicare (Health Insurance Act 1973): Universal coverage with bulk-billing incentives shaping how care is accessed and paid for.
Private health insurance: Heavily regulated and subsidized, sitting alongside the public system rather than as a thin add-on.
Pharmaceutical Benefits Scheme (PBS) and public hospitals: Dominate how medicines and inpatient care are financed and delivered.
Spending trajectory: Per capita spending has grown faster than GDP for decades.
NDIS: Costs have exploded beyond projections, adding to total health-adjacent spending pressure-see Welfare & Social Security for NDIS reform detail.

🛡️ Health Savings Accounts (HSAs) & Catastrophic Insurance

Personal accounts and catastrophic cover replace routine third-party payment for most working-age people, with transparency, tax advantages, and a residual safety net for the indigent.

Health Savings Accounts (HSAs): Mandatory or tax-advantaged accounts for routine and predictable care.
Catastrophic insurance: Dedicated true catastrophic cover for serious illness.
Medicare transition: Phased out for working-age adults, replaced by a safety net for the genuinely indigent.
Price transparency: Mandated so patients and purchasers can compare value.
Tax treatment: Deductions for all out-of-pocket medical expenses.

Why this is better

Third-party payer systems (public and regulated private): They destroy price signals, fuelling overconsumption and cost explosion.
HSAs: Restore skin-in-the-game, encourage preventive care, and reward shopping for value.
International evidence: Singapore, Switzerland, and US HSA experiments point to dramatically lower costs with maintained or superior outcomes.

In context

Peer

Health spend % GDP: AU / OECD avg / US / Singapore ~10.5 / ~9.3 / ~17 / ~5

AU sits slightly above the OECD average. Singapore's mixed-model HSA-plus-catastrophic system achieves comparable life-expectancy outcomes at roughly half AU's share of GDP.

Source reviewed 2026-04-19
Over time

AU per-capita health spend ~A$4,900 (2004) → ~A$9,600 (2023)

Real per-capita spend has roughly doubled in 20 years. AIHW attributes the bulk to higher unit prices and administrative cost, not improved access or outcomes.

Source reviewed 2026-04-19
Precedent

Singapore's 3M system

Medisave (mandatory HSA), MediShield Life (catastrophic insurance), and Medifund (safety net). Combined with heavy provider competition and published prices, Singapore delivers top-decile outcomes on roughly half the share of GDP that AU spends.

reviewed 2026-04-19

Implementation

📜 Legislation

Levels 🏛️ Federal 🏢 State 🤝 Intergovernmental

Affects

Health Insurance Act 1973 (Cth)
National Health Act 1953 (Cth) (PBS)
Private Health Insurance Act 2007 (Cth)

Federal: Health Savings Accounts and catastrophic insurance require new primary legislation or major amendment to the Health Insurance Act 1973; phasing out Medicare for working-age adults would be a staged legislative reform with a residual safety-net floor retained for the indigent. State: state health systems and public hospital funding arrangements renegotiated to reflect the shift from universal Medicare to a market-based model with government backstop. Intergovernmental: the National Health Reform Agreement renegotiated to redirect hospital funding from activity-based to outcome-linked block grants consistent with the new insurance framework.

⏳ Long Wait Times & Rationing

Elective surgery and specialist access lag badly-especially in the regions-while tight rules on training, foreign credentials, and scope worsen shortages; COVID exposed how brittle centralised delivery is for non-COVID care.

Elective surgery waitlists (public hospitals): Often 12-18 months or more for many procedures.
Specialist access: Poor in regional areas relative to need.
Workforce and regulation: Shortages worsened by heavy regulation of medical training, foreign qualifications, and scope of practice.
COVID-era lesson: Centralised systems proved fragile; lockdowns disrupted non-COVID care as well as pandemic response.

📉 Massive Deregulation of Providers

Expand who can deliver what care, align approvals with leading overseas regulators, and remove facility-expansion gatekeeping so supply can meet demand.

Scope of practice: Liberalisation for nurse practitioners, pharmacists, and telemedicine so more qualified providers can serve patients directly.
Drugs and devices: Faster approval aligned with leading regulators via mutual recognition (e.g. FDA, EMA).
Facility and market rules: Elimination of facility licensing and health-service planning restrictions that block new capacity.
Private hospitals and clinics: Free to expand without bureaucratic approval for routine growth.

Why this is better

Barriers to entry and practice: They stifle supply and innovation in how care is organised.
Workforce paradox: Australia imports many doctors while domestic training stays bottlenecked by rules and caps.
Deregulation payoff: More supply, lower costs, and room for new models such as direct primary care and ambulatory surgery centers.
Competition: Rewards quality and efficiency instead of protecting incumbents.

Implementation

📜 Legislation

Levels 🏛️ Federal 🏢 State 🤝 Intergovernmental

Affects

Health Practitioner Regulation National Law Act 2009 (scope of practice)
Therapeutic Goods Act 1989 (Cth) (drug and device approval)
State and territory health facility licensing legislation

Scope-of-practice liberalisation requires amendment to the Health Practitioner Regulation National Law via the Health Ministers' Meeting; faster drug approvals via mutual recognition can be legislated by amending the Therapeutic Goods Act 1989; removal of facility licensing and planning restrictions requires state legislative action.

📈 Centralization & Cost Explosion

Federal funding and national bodies tighten central control as admin and compliance costs rise, with little price transparency for patients at the point of care.

Federal control: Growing leverage through funding agreements and national bodies (e.g. Australian Commission on Safety and Quality in Health Care).
Administrative burden: Overhead and compliance costs trending up across the system.
Transparency gap: Little price transparency for patients at the point of care, making informed consumer choice almost impossible.
Welfare interfaces: Disability and aged-care funding streams interact with the health system; see Welfare & Social Security for NDIS and aged-care reform detail.

🏗️ Decentralised Delivery & Price Transparency

Replace top-down federal micro-management with outcome-linked block grants to states, radically simplified reporting, mandated price transparency, and competitive provider models.

Block-grant funding: Replace prescriptive federal funding agreements with outcome-linked block grants to states, giving hospitals and health networks operational autonomy while holding them accountable for results.
Admin simplification: Slash compliance and reporting layers; consolidate overlapping federal and state quality bodies into a single lean accreditation framework.
Price transparency: Mandate that every provider publish standardised pricing for common procedures and consultations so patients and insurers can compare value before committing.
Competitive provider models: Fund follows the patient-public and private hospitals compete on equal terms for elective and outpatient work, rewarding quality and efficiency over bed counts.

Why this is better

Centralised funding concentrates decision-making far from patients and clinicians, inflating admin overhead while adding little clinical value.
Price opacity is a root cause of cost escalation; transparency restores consumer pressure and lets HSAs (Section 1) function as intended.
Outcome-linked grants align incentives: states and providers that deliver better health results keep more funding flexibility, while underperformers face accountability.

Implementation

🤝 Agreement

Levels 🏛️ Federal 🏢 State 🤝 Intergovernmental

Affects

Health Insurance Act 1973 (Cth) (funding and billing)
National Health Reform Agreement (federal-state funding)
Australian Commission on Safety and Quality in Health Care Act 2006 (Cth)

Outcome-linked block grants require renegotiation of the National Health Reform Agreement and possible amendment to the Health Insurance Act 1973; admin simplification by consolidating quality bodies requires amendment to the ACSQHC Act 2006; price transparency can be mandated by new primary legislation or regulation under existing health Acts.

🏛️ Regulatory Capture & Innovation Barriers

The TGA and rules on private insurance blunt competition and delay access versus peers; weak price signals and a defensive litigation climate inflate low-value care.

TGA: Approval processes can be slower than peer countries (e.g. US FDA).
Private insurance rules: Community rating and guaranteed issue-style constraints distort markets and limit risk-appropriate pricing.
Competition and prices: Limited use of price signals or head-to-head competition between providers at the consumer level.
Defensive medicine: Medical indemnity and the litigation environment encourage defensive practice patterns and extra services.

🔬 Innovation & Personal Responsibility

Constitutional and policy moves that protect medical choice, accelerate access to innovation, tax-favour prevention, and let fair underwriting reflect lifestyle where actuarially justified.

Medical choice: Constitutional protection for medical choice and bodily autonomy.
Right to try: A strong right to try pathway for experimental treatments outside the slowest approval tracks where appropriate.
Prevention and wellness: Tax incentives for wellness, fitness, and preventive health spending or behaviours.
Personal responsibility in pricing: Insurance pricing may reflect lifestyle choices where actuarially fair, so incentives line up with long-run health behaviour.

Why this is better

Centralised control: Tends to suppress innovation and individual agency in treatment decisions and care models.
Patient and provider empowerment: Freedom paired with responsibility improves outcomes through competition, technology, and personal investment in health.
Incentive alignment: Shifts the system toward prevention and value instead of sheer volume of services.

Implementation

📜 Legislation

Levels 🏛️ Federal

Affects

Therapeutic Goods Act 1989 (Cth)
Private Health Insurance Act 2007 (Cth)
Commonwealth of Australia Constitution Act 1900 (medical choice and bodily autonomy)

Right-to-try pathways and faster approvals by amendment to the Therapeutic Goods Act 1989; insurance pricing reform by amendment to the Private Health Insurance Act 2007. Constitutional protection for medical choice and bodily autonomy is an optional add-on - enacted if later pursued as a chapter within the entrenched Bill of Rights (see Individual Rights › Entrenched Bill of Rights), which provides the broader rights framework that would ground medical autonomy as a constitutional guarantee rather than a statutory privilege - but the core statutory package stands on its own.

Requires Individual Rights › 📜 Entrenched Bill of Rights

Sources

Health Insurance Act 1973 (Cth) - Federal Register search · accessed 2026-04-12
AIHW - Australia's health / health expenditure · accessed 2026-04-12
Department of Health and Aged Care - Medicare overview · accessed 2026-04-12